AbbVie (ABBV) Prepaid Assets (2012 - 2026)
AbbVie (ABBV) posted quarterly Prepaid Assets of $6.6 billion for Q1 2026, up 20.27% YoY from $5.5 billion in Q1 2025, and up 5.04% sequentially from $6.3 billion in Q4 2025.
AbbVie (ABBV) Prepaid Assets (2012 - 2026) Analysis & Trends
AbbVie has disclosed Prepaid Assets across 15 years of filings, most recently posting $6.6 billion for Q1 2026.
- In Q1 2026, Prepaid Assets rose 20.27% year-over-year to $6.6 billion; the TTM figure through Mar 2026 stood at $6.6 billion (up 20.27% YoY), while the FY2025 annual figure was $6.3 billion, up 27.72% from the prior year.
- Prepaid Assets grew to $6.6 billion in Q1 2026, from $6.3 billion in the prior quarter.
- Over the last five years, Prepaid Assets for ABBV reached as high as $6.6 billion in Q1 2026 and fell as low as $4.4 billion in Q4 2022.
- The 5-year median for Prepaid Assets is $4.7 billion (2024), against an average of $5.0 billion.
- Annual changes were most pronounced in 2022 — Prepaid Assets dropped 11.86% — and 2025, when it climbed 27.72%.
- A 5-year view of Prepaid Assets shows it stood at $4.4 billion in 2022, then gained by 12.07% to $4.9 billion in 2023, then declined by 0.1% to $4.9 billion in 2024, then advanced by 27.72% to $6.3 billion in 2025, then climbed by 5.04% to $6.6 billion in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $6.6 billion, $6.3 billion, and $5.2 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - |
| 10 | Biogen | 30.87 Bn | 26.59 Bn | 1.82 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.61 Bn |
| Dec 31, 2025 | 6.29 Bn |
| Sep 30, 2025 | 5.16 Bn |
| Jun 30, 2025 | 5.20 Bn |
| Mar 31, 2025 | 5.50 Bn |
| Dec 31, 2024 | 4.93 Bn |
| Sep 30, 2024 | 4.58 Bn |
| Jun 30, 2024 | 4.72 Bn |
| Mar 31, 2024 | 4.61 Bn |
| Dec 31, 2023 | 4.93 Bn |
| Sep 30, 2023 | 4.54 Bn |
| Jun 30, 2023 | 4.54 Bn |
| Mar 31, 2023 | 4.46 Bn |
| Dec 31, 2022 | 4.40 Bn |
| Sep 30, 2022 | 4.57 Bn |
| Jun 30, 2022 | 4.51 Bn |
| Mar 31, 2022 | 4.72 Bn |
| Dec 31, 2021 | 4.99 Bn |
| Sep 30, 2021 | 4.33 Bn |
| Jun 30, 2021 | 4.10 Bn |